Abstract
Radiation therapy alone is the standard treatment for elderly patients with locally advanced non-small-cell lung cancer (NSCLC). However curative thoracic radiation therapy with concurrent chemotherapy may be feasible to selected elderly patients with NSCLC. This retrospective study was aimed to evaluate the safety and tolerability of concurrent chemoradiation therapy (CCRT) in patients aged 80 years or older.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date
